Diagnosis of Neurogenetic Disorders: Contribution of Next Generation Sequencing and Deep Phenotyping

The contribution of genomic variants to the aetiopathogenesis of both paediatric and adult neurological disease is being increasingly recognized. The use of next-generation sequencing has led to the discovery of novel neurodevelopmental disorders, as exemplified by the deciphering developmental diso...

Full description

Saved in:
Bibliographic Details
Main Author: McNeill, Alisdair (auth)
Format: Book Chapter
Published: MDPI - Multidisciplinary Digital Publishing Institute 2019
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03349naaaa2200577uu 4500
001 doab_20_500_12854_45005
005 20210211
020 |a books978-3-03921-611-6 
020 |a 9783039216109 
020 |a 9783039216116 
024 7 |a 10.3390/books978-3-03921-611-6  |c doi 
041 0 |a English 
042 |a dc 
100 1 |a McNeill, Alisdair  |4 auth 
245 1 0 |a Diagnosis of Neurogenetic Disorders: Contribution of Next Generation Sequencing and Deep Phenotyping 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2019 
300 |a 1 electronic resource (94 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The contribution of genomic variants to the aetiopathogenesis of both paediatric and adult neurological disease is being increasingly recognized. The use of next-generation sequencing has led to the discovery of novel neurodevelopmental disorders, as exemplified by the deciphering developmental disorders (DDD) study, and provided insight into the aetiopathogenesis of common adult neurological diseases. Despite these advances, many challenges remain. Correctly classifying the pathogenicity of genomic variants from amongst the large number of variants identified by next-generation sequencing is recognized as perhaps the major challenge facing the field. Deep phenotyping (e.g., imaging, movement analysis) techniques can aid variant interpretation by correctly classifying individuals as affected or unaffected for segregation studies. The lack of information on the clinical phenotype of novel genetic subtypes of neurological disease creates limitations for genetic counselling. Both deep phenotyping and qualitative studies can capture the clinical and patient's perspective on a disease and provide valuable information. This Special Issue aims to highlight how next-generation sequencing techniques have revolutionised our understanding of the aetiology of brain disease and describe the contribution of deep phenotyping studies to a variant interpretation and understanding of natural history. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
653 |a polymicrogyria 
653 |a n/a 
653 |a neurodegenerative disease 
653 |a next generation sequencing (NGS) 
653 |a inborn error of metabolism 
653 |a genetic biomarker 
653 |a deep learning 
653 |a TUBA1A 
653 |a Alzheimer's disease (AD) 
653 |a ataxia 
653 |a risk prediction 
653 |a p.(Arg2His) 
653 |a movement science 
653 |a tubulin 
653 |a R2H 
653 |a diagnosis 
653 |a machine learning 
653 |a metal storage disorders 
653 |a amyotrophic lateral sclerosis (ALS) 
653 |a glucocerebrosidase 
653 |a Parkinsonism 
653 |a cerebellar hypoplasia 
653 |a Gaucher disease 
653 |a disease phenotyping 
653 |a tubulinopathy 
653 |a Parkinson's disease (PD) 
653 |a dementia 
653 |a Parkinson's disease 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/1735  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/45005  |7 0  |z DOAB: description of the publication